|
Volumn 72, Issue 4, 2001, Pages 587-597
|
Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients
a b a c a a a a b b a a a a a a
b
BIOGEN
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
CYCLOSPORIN A;
GLYCOPROTEIN GP 39;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY HU5C8;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISONE;
UNCLASSIFIED DRUG;
ALLOGRAFT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INHIBITION;
GRAFT SURVIVAL;
HISTOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
RHESUS MONKEY;
|
EID: 0035959443
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-200108270-00006 Document Type: Article |
Times cited : (40)
|
References (20)
|